Dublin, April 18, 2023 (GLOBE NEWSWIRE) -- The "Cloning & Mutagenesis Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F Segmented By Gene Type (Standard v/s Complex), By Product Type (Cloning Kits v/s Mutagenesis Kits), By Technique, By Application, By End User, By Region and Competition" report has been added to ResearchAndMarkets.com's offering.
The Global Cloning & Mutagenesis Market is anticipated to witness impressive growth during the forecast period.
Companies Mentioned
- Agilent Technologies, Inc.
- Eurofins Scientific SE
- Sartorius AG
- Collecta, Inc.
- Codex DNA Inc.
- Lonza Group AG
- Charles River Laboratories International, Inc.
- TransGene Biotech Co. Ltd.
- Takara Bio, Inc.
- Thermo Fisher Scientific Inc.
This can be ascribed to the growing cloning approaches in different genetic applications like reproductive cloning and genetic cloning. Additionally, various new product launches in the cloning and mutagenesis market, which will demand cloning and mutagenesis kits, along with government organizations investing in stem cell research for the development of new treatments and therapy, have significantly increased the demand for cloning and mutagenesis across different parts of the globe.
Additionally, the growing geriatric population across the globe, which is susceptible to different kinds of diseases and obesity, is further expected to increase the demand for cloning and mutagenesis, thereby fuelling market growth through 2028.
Besides, growing awareness about the advantages of using gene therapy and diagnosis, along with increasing healthcare expenditure on chronic disease treatment across the globe, are further expected to support the cloning and mutagenesis market during the forecast period. In 2022, an estimated 66,470 people (48,520 men and 17,950 women) will be diagnosed with head and neck cancer in the United States.
Increasing Research and Development Activities in Cancer and Other Chronic Disorders Fueling the Market Growth
Increasing research and development regarding cloning and mutagenesis for the development of cancer therapies and other rare disorders is expected to create lucrative growth in the market during the forecast period. Government organizations are focusing on developed infrastructure with higher profits.
Different types of innovative and ethically accepted therapies available for cancer therapy, along with the increasing development of new products, are expected to boost market growth over the years. In May 2020, Takara Bio announced a collaboration with AGC Biologics, and their businesses would collaborate on a prophylactic DNA vaccine against COVID-19 with AGC Biologics manufacturing the plasmid DNA intermediate for the vaccine.
As public-funded research is getting a boost from bodies such as the European Commission and the Japan Agency for Medical Research and Development. In 2020, an estimated 276,480 new cases of invasive breast cancer will be diagnosed in women in the U.S. as well as 48,530 new cases of non-invasive (in situ) breast cancer. The increasing cloning of genes for the synthesis of antibiotics, hormones, and vitamins, among others, for the treatment of issues such as cystic fibrosis is propelling the market growth.
Increasing Investment by Government Organizations is Driving the Market Growth
Important factors which are expected to create lucrative growth in the market include a favorable funding scenario for gene synthesis and cloning services, along with technological advancement in the treatment, followed by research, subcloning services, and rising synergistic activities in the market. Increasing demand for gene therapy and growing adoption of novel and advanced DNA cloning technologies are expected to create a lucrative growth of the market during the forecast period.
Report Scope:
In this report, global cloning & mutagenesis market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:
Cloning & Mutagenesis Market, By Gene Type:
- Standard
- Complex
Cloning & Mutagenesis Market, By Product Type:
- Cloning Kits
- Mutagenesis Kits
Cloning & Mutagenesis Market, By Technique:
- Topo PCR Cloning
- Blunt End Cloning
- Seamless Cloning
- Site-Directed Mutagenesis
- Others
Cloning & Mutagenesis Market, By Application:
- Gene Synthesis
- Gene Expression
- Gene Therapy
- Vaccine Research
- Others
Cloning & Mutagenesis Market, By End User:
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutions
- Others
Cloning & Mutagenesis Market, By Region:
- North America
- United States
- Canada
- Mexico
- Europe
- France
- Germany
- United Kingdom
- Italy
- Spain
- Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- South America
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
For more information about this report visit https://www.researchandmarkets.com/r/e2fh5r
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
